Colony Group LLC Palatin Technologies Inc Transaction History

Colony Group LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 13, 2020	SELL	$0.41 - $0.73 $4,141 - $7,373	-10,100 Closed	0 $0
Q4 2019 Feb 18, 2020	BUY	$0.75 - $0.89 $75 - $89	100 Added 1.0%	10,100 $8,000
Q3 2019 Nov 26, 2019	SELL	$0.78 - $1.09 $7,800 - $10,900	-10,000 Reduced 50.0%	10,000 $9,000
Q2 2019 Aug 19, 2019	BUY	$0.98 - $1.64 $19,600 - $32,800	20,000 New	20,000 $23,000

2.94K

Ticker PTN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,290,480
Market Cap $8.83M
Description
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...

Get notified when there are updates to the investment portfolio of Colony Group LLC, based on Form 13F filings with the SEC.

Stay updated on Colony Group LLC with notifications on news.